Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs 10X Genomics Inc (TXG) Price & Performance

NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.32, up 5.7% in 24 hours, reflecting strong bullish momentum from its underlying asset NVIDIA. Technical indicators show a bullish trend with moving averages supporting upward movement, though the RSI suggests mild overbought conditions. Recent news highlights NVDL's leveraged exposure to NVIDIA's AI-driven growth, with the ETF capturing amplified returns from NVDA's performance, including a 12.66% year-to-date gain as of June 8, 2026, per 24/7 Wall Street.

The outlook for NVDL is tied to NVIDIA's continued dominance in AI chips, with potential for significant gains during bullish phases but high volatility risks due to daily reset leverage. Key risks include compounded losses during NVDA downturns, as seen in a 12% single-day drop on June 5, 2026. Investors should weigh the ETF's amplified returns against its inherent decay in volatile markets.

TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.

Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.